Yayın: Vasoactive Intestinal Peptide (VIP) Treatment of Parkinsonian Rats Increases Thalamic Gamma-Aminobutyric Acid (GABA) Levels and Alters the Release of Nerve Growth Factor (NGF) by Mast Cells
| dc.contributor.author | Tunçel, Muzaffer | |
| dc.contributor.author | Öncü-Kaya, Elif Mine | |
| dc.contributor.author | Muzaffer Tunçel | |
| dc.contributor.author | Elif Mine Öncü-Kaya | |
| dc.contributor.author | Varol Şahıntürk | |
| dc.contributor.author | Mustafa Çelık | |
| dc.contributor.orcid | 0000-0003-1410-740X | |
| dc.contributor.orcid | 0000-0003-2700-5840 | |
| dc.contributor.orcid | 0000-0002-8238-6300 | |
| dc.contributor.orcid | 0000-0002-0423-7000 | |
| dc.contributor.orcid | 0000-0003-2317-3644 | |
| dc.contributor.orcid | 0000-0003-4102-1564 | |
| dc.date.accessioned | 2025-11-13T09:54:27Z | |
| dc.date.issued | 2009-12-01 | |
| dc.identifier.doi | https://doi.org/10.1007/s12031-009-9307-3 | |
| dc.identifier.endpage | 287 | |
| dc.identifier.issn | 0895-8696 | |
| dc.identifier.issue | 2 | |
| dc.identifier.openalex | W2021952901 | |
| dc.identifier.startpage | 278 | |
| dc.identifier.uri | https://hdl.handle.net/11421/2559 | |
| dc.identifier.uri | https://doi.org/10.1007/s12031-009-9307-3 | |
| dc.identifier.volume | 41 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Journal of Molecular Neuroscience | |
| dc.rights | restrictedAccess | |
| dc.subject | Substantia nigra | |
| dc.subject | Pars reticulata | |
| dc.subject | Vasoactive intestinal peptide | |
| dc.subject | Dopamine | |
| dc.subject | Neuroscience | |
| dc.subject | Internal medicine | |
| dc.subject | Globus pallidus | |
| dc.subject | Endocrinology | |
| dc.subject | GABAergic | |
| dc.subject | Basal ganglia | |
| dc.subject | Striatum | |
| dc.subject | Nerve growth factor | |
| dc.subject | Chemistry | |
| dc.subject | Nigrostriatal pathway | |
| dc.subject | Dopaminergic | |
| dc.subject | Neuropeptide | |
| dc.subject | Biology | |
| dc.subject | Central nervous system | |
| dc.subject | Medicine | |
| dc.subject | Inhibitory postsynaptic potential | |
| dc.subject | Receptor | |
| dc.subject.sdg | 3 | |
| dc.title | Vasoactive Intestinal Peptide (VIP) Treatment of Parkinsonian Rats Increases Thalamic Gamma-Aminobutyric Acid (GABA) Levels and Alters the Release of Nerve Growth Factor (NGF) by Mast Cells | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5019804257 | |
| local.authorid.openalex | A5040071274 |
